Subscribe
Menu
Login
Search
Login
News & Opinion
Publications
AN INTERACTIVE EXPERIENCE
Current Issue
May 2022, Issue 2
Preview This Issue
Archives
Features
Quarterly Magazine
Current Issue
Spring 2022
Preview This Issue
Archives
Features
Categories
Biochemistry
Cancer
Cell Biology
Community
Drug Development
Environment
Evolution
Genetics
Immunology
Microbiology
Neuroscience
Physiology
Public Health
Zoology
Multimedia
Crossword Puzzles
Infographics
Science Snapshot
Videos
Webinars
Research Resources
Podcasts
Events
Infographics
eBooks
Videos
The Scientist University
Research Products Blog
Articles
Subscribe
Medical Researcher and Philanthropist Laszlo Bito Dies at 87
His work contributed to the development of the drug Xalatan, a treatment for glaucoma.
ABOVE: ANDREA PÓK
Medical Researcher and Philanthropist Laszlo Bito Dies at 87
Medical Researcher and Philanthropist Laszlo Bito Dies at 87
His work contributed to the development of the drug Xalatan, a treatment for glaucoma.
His work contributed to the development of the drug Xalatan, a treatment for glaucoma.
ABOVE: ANDREA PÓK
Home
Subjects
Ocular
Ocular
Algorithm Spots COVID-19 Cases from Eye Images: Preprint
Anthony King | Sep 21, 2020
A small study shows artificial intelligence can pick out individuals with coronavirus infections, but ophthalmologists and AI experts say the approach is far from proven to be capable of distinguishing infections with SARS-CoV-2 from other ills.
Quasi-Lymphatic System in the Rodent Eye Clears Waste
Abby Olena | Apr 16, 2020
Two rodent models of glaucoma have defects in the waste drainage system.
Bacteria to Blame?
Rina Shaikh-Lesko | Aug 18, 2015
T cells activated in the microbe-dense gut can spark an autoimmune eye disease, a study shows.
Visualizing the Ocular Microbiome
Rina Shaikh-Lesko | May 12, 2014
Researchers are beginning to study in depth the largely uncharted territory of the eye’s microbial composition.